U.S. Bancorp
USB
$58.73
+2.33%
U.S. Bancorp is one of the largest U.S. regional banks, operating roughly $725 billion in assets across a 26-state branch footprint concentrated in the Midwest and West, with a diversified product set spanning retail and commercial banking, credit cards, mortgages, payments, trust, wealth management, and capital markets. Its distinctive identity rests on a fee-rich, payments-heavy business mix — anchored by Elavon merchant acquiring and a top-tier corporate trust franchise — that has historically delivered higher-quality, less rate-sensitive revenue than pure spread-lending peers, positioning it as the premium-quality operator within the regional bank cohort. The current investor narrative centers on record quarterly revenue, expanding fee income, and the anticipated resumption of share buybacks, which bulls argue support a re-rating toward historical valuation norms. That optimism is being tested by a sharp late-summer pullback in the shares, a downgrade wave arguing large-cap banks are 'priced for perfection,' and a Q3 reporting season where peers have been punished for declining capital ratios and rising credit provisions.…
USB
U.S. Bancorp
$58.73
Related headlines
Investment Opinion: Should I buy USB Today?
Rating: Buy (moderate conviction). The core thesis is that U.S. Bancorp offers a high-quality, fee-rich franchise with expanding margins and a 4.22% dividend yield at a reasonable 11.55x trailing earnings, with the analyst consensus 'buy' rating (mean 1.79) and $68.45 average target implying 16.6% upside. The stock's 28.65% one-year gain versus SPY's 15.53% confirms relative strength, though recent consolidation warrants patience.
Supporting evidence: (1) net margin expanded to 19.93% from 17.24% YoY, with gross margin at 65.44%; (2) EPS grew from $1.03 to $1.35 over five quarters, with consensus $5.53 implying ~15% growth; (3) TTM free cash flow of $12.384B yields ~14.9% of market cap, funding the 4.22% dividend and resumed buyback; (4) the 0.53 PEG ratio and 1.27x P/B are near the middle-to-upper end of the regional bank range but defensible given superior fee mix and 11.62% ROE. The 16.6% upside to the average target is meaningful relative to the 4.22% yield.
Key risks that could invalidate the thesis: a credit deterioration cycle raising provisions and pressuring capital ratios (as seen in Q3 peer results), a continued momentum breakdown below the $56 support opening a test of $52-$53, and a downgrade-driven rotation out of large-cap banks. The rating would upgrade to a stronger Buy if the stock reclaims $62-$63 with improving relative strength, or downgrade to Hold if it breaks below $56 on volume or if net margin contracts below 18%. Valuation verdict: fairly valued to modestly undervalued relative to its own history and peers, with the 4.22% yield providing a margin of safety.
Sign up to view all
USB 12-Month Price Forecast
The forward view is balanced: the franchise quality, margin expansion, and 4.22% yield support a constructive base case, but the stock's premium-to-recent-band valuation and negative momentum argue against aggressive upside. The base case (50% probability) targets $65-$70, aligned with the analyst average of $68.45, assuming mid-single-digit revenue growth and stable credit. An upgrade to bullish would require the stock to reclaim $62-$63 with improving relative strength and confirmation of buyback acceleration; a downgrade to bearish would follow a break below $56 or net margin falling below 18%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on U.S. Bancorp's 12-month outlook, with a consensus price target around $68.50 and implied upside of +16.6% versus the current price.
Average Target
$68.50
0 analysts
Implied Upside
+16.6%
vs. current price
Analyst Count
—
covering this stock
Price Range
$61 - $76
Analyst target range
Coverage is robust, with 22 analysts and a consensus recommendation of 'buy' (mean rating 1.79 on a 1-5 scale where lower is more bullish), and an average target price of $68.45 implying roughly 16.6% upside from the $58.73 current price. The consensus leans clearly bullish, and the $5.53 average EPS estimate (range $5.4351-$5.611) against a 10.08x forward multiple frames the target as achievable through modest multiple normalization rather than heroic growth assumptions. Recent institutional actions skew constructive: Evercore ISI upgraded to Outperform from In Line and JP Morgan moved to Neutral from Underweight in July, while HSBC, RBC Capital, Barclays, Oppenheimer, Truist, and Wells Fargo all maintained Buy/Outperform/Overweight ratings through late September. The target range of $61.00 to $76.00 is moderately wide — the low end implies just 3.9% upside and effectively prices a stalled re-rating or margin/credit deterioration, while the $76 high assumes multiple expansion toward 13x-14x forward earnings on accelerating fee income and buyback-driven EPS growth. The $15 spread (about 22% of the current price) signals real disagreement about the pace of capital return and credit normalization rather than deep uncertainty about the franchise, and the clustering of maintained ratings with only incremental upgrades suggests steady conviction rather than a catalyst-driven re-rating.
Bulls vs Bears: USB Investment Factors
The bull case currently rests on stronger evidence: margin expansion (net margin 19.93% vs. 17.24% a year ago), a 4.22% dividend yield, a ~14.9% FCF yield, and a 16.6% analyst target upside all point to a high-quality franchise trading at a reasonable 11.55x earnings. However, the bear case has gained traction with three-month relative underperformance of -9.67 versus SPY and a downgrade wave warning that large-cap banks are priced for perfection. The single most important tension is whether the anticipated buyback resumption and fee-income growth can drive EPS toward the $5.53 consensus and justify multiple normalization, or whether credit normalization and capital-ratio pressure force a de-rating toward the $61 low target. Resolution of this debate likely hinges on Q3 credit provisions and management's capital return commentary.
Bullish
- Fee-rich mix drives margin expansion: Q2 2026 net margin reached 19.93%, up from 17.24% a year earlier, while gross margin improved to 65.44% from 61.49%. The fee-based institutional and payments segments (Wealth/Corporate/Commercial at $3.482B and Payment Services at $1.719B) are the growth engines, insulating revenue from pure spread compression.
- Attractive valuation with 16.6% upside: At 11.55x trailing and 10.08x forward earnings, USB trades at a discount to its own recent PE band top of 11.8x and carries a 0.53 PEG ratio. The analyst average target of $68.45 implies 16.6% upside, with 22 analysts at a consensus 'buy' rating (mean 1.79).
- Strong capital return and FCF yield: TTM free cash flow of $12.384B against an $82.97B market cap implies a ~14.9% FCF yield, comfortably funding the 4.22% dividend (46.2% payout) and the recently resumed buyback. Q2 operating cash flow of $4.82B and $66.49B cash confirm ample internal funding.
- Earnings growth trajectory intact: Diluted EPS climbed from $1.03 in Q1 2025 to $1.35 in Q2 2026, and the $5.53 consensus EPS estimate implies roughly 15% growth from the current run-rate. Revenue rose 3.75% YoY to $10.923B, the highest of the last six quarters.
Bearish
- Momentum has clearly decelerated: The stock is down 6.98% over three months and 1.67% over one month, with relative strength of -9.67 and -2.89 versus SPY respectively. The 180-day series shows a lower-highs sequence from the $65.42 August 14 peak into the mid-$50s, signaling a corrective consolidation.
- Valuation near top of recent band: At 11.55x PE and 1.27x P/B, USB sits near the top of its recent eight-quarter band of roughly 9.9x-11.8x and well above the 0.96x-1.10x P/B troughs of 2023. The stock is no longer the deep-value opportunity it was, leaving less margin of safety.
- Downgrade wave and 'priced for perfection': A July downgrade wave argued large-cap banks are priced for perfection, with analysts recommending rotation into super-regionals. Q3 peer results (e.g., Citigroup) were punished for declining capital ratios and rising credit provisions, a read-through risk for USB.
- Modest revenue growth limits re-rating: Revenue growth of 3.75% YoY is unspectacular for a bank and consistent only with mid-single-digit expansion. Without acceleration in fee income or net interest income, multiple expansion toward the $76 high target (13x-14x forward) may prove difficult.
USB Technical Analysis
USB is in a sustained but stalling uptrend: the stock is up 28.65% over the past year versus 15.53% for SPY, a 13.12-point relative-strength outperformance, yet at $58.73 it sits only about 60.4% of the way through its 52-week range of $45.02 to $66.08 — roughly 11.1% below the high and 30.5% above the low. That mid-to-upper range positioning signals a trend that has lost its upside momentum rather than one pressing against resistance, leaving the stock in a corrective consolidation within a longer-term advance. Short-term momentum has clearly decelerated and diverged from the annual trend: the stock is down 1.67% over one month and 6.98% over three months, against a 3.16% six-month gain and 8.90% YTD advance, producing relative strength of -2.89 over one month and -9.67 over three months versus SPY. The 180-day price series shows a clear peak near $65.42 on August 14 followed by a lower-highs sequence into the mid-$50s, and the 2.33% single-day bounce on October 16 off the $56.17 October 7 low suggests buyers are defending the mid-$50s; the 3.31 short ratio indicates short interest is moderate rather than crowded. Key support sits at the $56-$57 shelf established in October, with the 52-week low at $45.02 as the deeper structural floor, while resistance is the $65.42-$66.08 August/52-week-high zone; a breakout above $66 would confirm trend resumption toward new highs, whereas a decisive break below $56 would validate the three-month downtrend and open a test of the $52-$53 May lows. With a maximum drawdown of -16.21% over the period and no beta provided, the stock's realized volatility has been meaningful but orderly, and the 17.5 million share volume on the up day supports the case for near-term stabilization.
Beta
1.02
1.02x market volatility
Max Drawdown
-16.2%
Largest decline past year
52-Week Range
$45-$66
Price range past year
Annual Return
+28.7%
Cumulative gain past year
| Period | USB Return | S&P 500 |
|---|---|---|
| 1m | -1.7% | +0.2% |
| 3m | -7.0% | +2.9% |
| 6m | +3.2% | +8.4% |
| 1y | +28.7% | +14.9% |
| ytd | +8.9% | +11.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
USB Fundamental Analysis
Revenue is growing at a modest but improving pace: Q2 2026 revenue of $10.923 billion rose 3.75% year over year from $10.528 billion, and the sequential progression from $10.352 billion (Q1 2025) through $10.528 billion, $11.005 billion, $10.976 billion, $10.835 billion, and $10.923 billion shows a stable-to-rising trajectory with the Q2 2026 print the highest of the last six quarters. Segment data for the latest period shows Wealth, Corporate, Commercial and Institutional Banking at $3.482 billion, Consumer and Business Banking at $2.325 billion, and Payment Services at $1.719 billion, with Treasury and Corporate Support a -$238 million drag — confirming that the fee-based institutional and payments engines, not spread lending, are the growth drivers. The 3.75% growth rate is unspectacular for a bank but consistent with a high-quality franchise compounding fee revenue, and the consensus revenue estimate of $54.07 billion implies continued mid-single-digit expansion. Profitability is solid and expanding: Q2 2026 net income was $2.177 billion on a 19.93% net margin, up from $1.815 billion and a 17.24% margin in Q2 2025, while gross margin improved to 65.44% from 61.49% a year earlier and operating margin reached 24.90% versus 21.78%. The multi-quarter margin arc — net margin of 16.51% in Q1 2025, 17.24%, 18.18%, 18.69%, 17.95%, and 19.93% in Q2 2026 — shows steady expansion, and diluted EPS climbed from $1.03 to $1.35 over the same span, with the 22.20% operating margin and 17.68% net margin both healthy for regional banking. Balance-sheet and cash-flow metrics reflect a leveraged but liquid institution: debt-to-equity is 1.20x, ROE is 11.62% and ROA just 1.2% (typical for banks given the ~10.6x equity multiplier), while TTM free cash flow of $12.384 billion against an $82.97 billion market cap implies a roughly 14.9% FCF yield that comfortably funds the 4.22% dividend (46.2% payout ratio) and the recently resumed buyback. The current ratio of 0.255 is not meaningful for a bank balance sheet, but $66.49 billion of cash at period end and $4.82 billion of Q2 operating cash flow confirm ample internal funding capacity, with the $3.083 billion of Q2 debt repayment and $904 million of dividends paid showing management is deleveraging while returning capital.
Quarterly Revenue
$10.9B
2026-06
Revenue YoY Growth
+3.8%
YoY Comparison
Gross Margin
65.4%
Latest Quarter
Free Cash Flow
$12.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is USB Overvalued?
Because U.S. Bancorp is solidly profitable — Q2 2026 net income of $2.177 billion and trailing EPS positive — the PE ratio is the appropriate primary metric, and at 11.55x trailing versus 10.08x forward the stock trades at a modest discount to its own forward multiple, implying the market expects roughly 15% EPS growth (consistent with the $5.53 consensus estimate versus the current run-rate). The 1.27x price-to-book and 1.94x price-to-sales are the more telling bank-specific anchors, and the 0.53 PEG ratio suggests the earnings multiple is low relative to expected growth. Against a regional bank sector that typically trades in the 10x-13x PE and 1.0x-1.5x P/B range, USB's 11.55x PE and 1.27x P/B sit near the middle-to-upper end — a modest premium to the group average that is defensible given its superior fee mix, 17.68% net margin, and 11.62% ROE, though the 4.31x EV/sales and 10.97x EV/EBITDA are less informative for a deposit-funded lender. The 4.22% dividend yield is a meaningful support for valuation and well above the sector norm. Historically, USB's PE has ranged from roughly 8.7x (Q1 2023) to 22.1x (Q4 2023, distorted by depressed earnings), with the more recent eight-quarter band running about 9.9x-11.8x; at 11.55x the stock is near the top of that recent band, while its 1.27x P/B is close to the 1.27x-1.39x readings of the past year and far above the 0.96x-1.10x troughs of 2023. The read-through is that the market is pricing in optimistic-but-not-euphoric expectations: the stock is no longer the deep-value 0.96x book opportunity it was in mid-2023, but at 11.5x earnings with a 4.2% yield it is not stretched relative to its own history either.
PE
11.5x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 9x~14x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
11.0x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on credit quality and capital adequacy. USB's debt-to-equity of 1.20x and ROA of only 1.2% mean earnings are sensitive to provision increases; Q3 peer results already showed investors punishing declining capital ratios and rising credit provisions. Revenue growth of 3.75% YoY is modest, and any slowdown in the fee-rich Payment Services ($1.719B) or Wealth/Corporate ($3.482B) segments would remove the primary growth driver, while the 46.2% payout ratio leaves limited room for dividend growth if earnings stall.
Market and competitive risks include valuation compression and sector rotation. At 11.55x PE and 1.27x P/B, USB trades near the top of its recent 9.9x-11.8x PE band, leaving little cushion if the 'priced for perfection' downgrade thesis gains traction. The July downgrade wave explicitly recommended rotating into super-regional banks, and with three-month relative strength of -9.67 versus SPY, momentum investors may continue to exit. Regulatory capital requirements and macro sensitivity to rate cuts could further pressure net interest income.
Worst-case scenario: a credit cycle deterioration combined with a stalled buyback and multiple compression toward the 2023 trough P/B of ~0.96x would imply a price near $44-$46, roughly in line with the 52-week low of $45.02. From the current $58.73, that represents a decline of approximately -23% to -25%. A less severe but more likely adverse path to the analyst low target of $61.00 would still represent only 3.9% upside, effectively a flat-to-negative return if the stock first corrects toward the $52-$53 May lows, a -10% to -11% drawdown from current levels.
FAQ
Ranked by severity: (1) Credit risk — rising provisions and declining capital ratios, as punished in Q3 peer results, could pressure the 1.20x debt-to-equity balance sheet and limit buybacks; (2) Valuation compression — at 11.55x PE near the top of its recent band, the 'priced for perfection' downgrade wave could drive multiple compression toward 9.9x, implying a test of $52-$53; (3) Momentum breakdown — three-month relative strength of -9.67 versus SPY and a lower-highs sequence from $65.42 signal trend deterioration, with a break below $56 opening the 52-week low zone; (4) Macro/rate sensitivity — net interest income compression from rate cuts could offset fee growth, though the fee-rich mix provides some insulation.
The 12-month forecast has three scenarios: bull case (30% probability) targeting $72-$76 on buyback acceleration and multiple expansion to 13x-14x forward earnings; base case (50% probability) targeting $65-$70, aligned with the $68.45 analyst average, on mid-single-digit revenue growth and stable credit; and bear case (20% probability) targeting $52-$61 on rising provisions and multiple compression toward 9.9x-10.5x. The base case is most likely, assuming net margin holds between 18% and 20% and the buyback resumes at a measured pace. The key assumption is that fee income in Payments and Wealth/Corporate continues to offset spread compression.
USB appears fairly valued to modestly undervalued. At 11.55x trailing and 10.08x forward earnings, it sits near the top of its recent eight-quarter PE band of roughly 9.9x-11.8x, but well below the distorted 22.1x Q4 2023 reading and above the 0.96x-1.10x P/B troughs of 2023. The 1.27x P/B and 1.94x P/S are near the middle-to-upper end of the regional bank range of 10x-13x PE and 1.0x-1.5x P/B, a modest premium justified by the superior fee mix and 4.22% yield. The 0.53 PEG ratio suggests the earnings multiple is low relative to expected growth. The market is pricing in optimistic-but-not-euphoric expectations of roughly 15% EPS growth toward $5.53.
From a risk/reward perspective, USB offers a balanced proposition: 16.6% upside to the $68.45 analyst average target against roughly 10-11% downside to the $52-$53 May lows, with a 4.22% dividend yield cushioning returns. The stock trades at 11.55x trailing and 10.08x forward earnings, near the middle-to-upper end of its regional bank peer range but supported by a 17.68% net margin and 11.62% ROE. The biggest downside risk is a credit deterioration cycle that pressures provisions and capital ratios, as seen in Q3 peer results. It is a good buy for income-oriented, long-term investors comfortable with bank-sector cyclicality, particularly on pullbacks toward the $56 support shelf; momentum-focused traders may prefer to wait for a reclaim of $62-$63.
USB is best suited for long-term holding with a minimum suggested horizon of 12-18 months. The 4.22% dividend yield (46.2% payout ratio) and ~14.9% FCF yield reward patient income investors, while the 28.65% one-year gain versus SPY's 15.53% shows the stock can deliver capital appreciation through a cycle. Short-term trading is less attractive given the current corrective consolidation (down 6.98% over three months) and the absence of a clear catalyst until the buyback announcement and Q3 earnings. The moderate short ratio of 3.31 and -16.21% max drawdown indicate orderly volatility rather than speculative extremes, supporting a hold-through-cycle approach.